What is the role of Relpreve (roflumilast) in treating Chronic Obstructive Pulmonary Disease (COPD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What is the recommended treatment for a patient with severe Chronic Obstructive Pulmonary Disease (COPD) and a history of exacerbations, with a Forced Expiratory Volume in one second (FEV₁) of less than 50% predicted, chronic bronchitis, and a history of at least one hospitalization for a COPD exacerbation in the previous year, considering roflumilast (Daxas) as a potential option?
What is the dose of Daliresp (Roflumilast)?
What add-on therapy to Chronic Obstructive Pulmonary Disease (COPD) treatment is considered after Trelegy (fluticasone furoate/umeclidinium/vilanterol)?
What are the initial workup and treatment for Chronic Obstructive Pulmonary Disease (COPD)?
Is it safe to co‑administer roflumilast (Daliresp) and phenytoin, and what monitoring or dose adjustments are recommended?
Is incision and drainage (I&D) recommended for a 2-year-old with a scalp abscess?
Why is a patient with a cortisol level of 11.5 and hyponatremia (sodium level of 124) still hyponatremic despite taking 1000mg of sodium chloride (NaCl) tablets daily?
Is a combination of hyaluronic acid and Kenocart (diclofenac) effective for osteoarthritis treatment?
What is the appropriate management for an outpatient with adrenal insufficiency and hyponatremia in an assisted living setting?
What is the role of long-acting injectable olanzapine (olanzapine) in managing schizophrenia or bipolar disorder?
What is the best treatment approach for a patient with End-Stage Renal Disease (ESRD) who develops line sepsis due to Methicillin-Resistant Staphylococcus Aureus (MRSA)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.